Detalhe da pesquisa
1.
Clinical Impact of an Antibiotic Time Out Initiative at an Academic Medical Center.
Hosp Pharm
; 56(4): 343-346, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34381272
2.
Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second Look.
Biol Blood Marrow Transplant
; 26(8): e198-e201, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32304873
3.
Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology.
Transplant Cell Ther
; 29(1): 10-18, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36273782
4.
Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022).
Transplant Cell Ther
; 28(12): 810-821, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36103987
5.
Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients.
Transplant Cell Ther
; 28(2): 116.e1-116.e7, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34785398
6.
Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer Patients.
medRxiv
; 2021 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34704093
7.
Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients.
Cell Biosci
; 11(1): 197, 2021 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34802457